Načítá se...
Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice
Despite advancements in disease management, sickle cell nephropathy, a major contributor to mortality and morbidity in patients, has limited therapeutic options. Previous studies indicate hydroxyurea, a commonly prescribed therapy for sickle cell disease (SCD), can reduce renal injury in SCD but the...
Uloženo v:
| Vydáno v: | Am J Physiol Regul Integr Comp Physiol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Physiological Society
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8163606/ https://ncbi.nlm.nih.gov/pubmed/33624556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpregu.00205.2020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|